Role of immune checkpoint inhibitors combined with chemotherapy in recurrent drug‐resistant gestational trophoblastic neoplasia: Four case reports and literature review
Abstract Background Multiple studies have confirmed that programmed cell death 1 (PD‐1) and programmed cell death ligand 1 (PD‐L1) is widely expressed in gestational trophoblastic neoplasia (GTN) tissues. Therefore, immune checkpoint inhibitors may be an option for the treatment of recurrent and dru...
Main Authors: | Weiqing Liu, Yukai Zhu, Ya Wang, Rong Li, Dongling Zou, Rui Chen, Lu Yang, Yu Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-03-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.2016 |
Similar Items
-
The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia
by: Yuanyuan Liu, et al.
Published: (2023-01-01) -
Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017
by: Yujia Kong, et al.
Published: (2020-04-01) -
Comparison between single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
by: Leila Mousavi Seresht, et al.
Published: (2023-01-01) -
Pulmonary arterial venous malformations as primary manifestation of gestational trophoblastic neoplasia
by: Abigail Cain, et al.
Published: (2020-11-01) -
Resistance to Single-agent Chemotherapy for Low-risk Gestational Trophoblastic Neoplasia
by: Shahrzad Sheikhhasani, et al.
Published: (2023-01-01)